BriaCell Therapeutics (BCTXF) Short Interest Ratio & Short Volume

Short interest is the volume of BriaCell Therapeutics shares that have been sold short but have not yet been covered or closed out. As of February 12th, traders have sold 1,200 shares of BCTXF short. Learn More on BriaCell Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCTXF shares currently have a short interest ratio of 1.0. Learn More on BriaCell Therapeutics's short interest ratio.

BriaCell Therapeutics saw a increase in short interest in February. As of February 12th, there was short interest totaling 1,200 shares, an increase of 500.0% from the previous total of 200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to BriaCell Therapeutics: Salarius Pharmaceuticals, Inc. (6.72%), Panbela Therapeutics, Inc. (2.36%), Petros Pharmaceuticals, Inc. (3.57%), Bio-Path Holdings, Inc. (8.97%), 180 Life Sciences Corp. (8.36%), Clearmind Medicine Inc. (6.12%), Qualigen Therapeutics, Inc. (1.74%), CohBar, Inc. (0.59%), Intellipharmaceutics International Inc. (0.09%), Aoxing Pharmaceutical Company, Inc. (0.00%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Aon plc ($5.62 billion), Charter Communications, Inc. ($5.35 billion), Analog Devices, Inc. ($5.07 billion), Snap Inc. ($3.60 billion), Futu Holdings Limited ($2.92 billion), Palantir Technologies Inc. ($2.55 billion), Airbnb, Inc. ($2.52 billion), Snowflake Inc. ($2.38 billion), Peloton Interactive, Inc. ($2.22 billion), and The Kroger Co. ($2.07 billion). View all of the most shorted stocks.

Short selling BCTXF is an investing strategy that aims to generate trading profit from BriaCell Therapeutics as its price is falling. BCTXF shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for BriaCell Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BCTXF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCTXF, twice per month. The most recent reporting period available is February, 12 2021.